Results
RPG Life Sciences Q1 Revenue Up 15.8%, Margin Expands
RPG Life Sciences reported Q1 FY27 revenue growth of 15.8% to ₹195.7 crore with EBITDA margin expansion of 40 bps to 24.5%.
Domestic Formulations outperformed Indian pharma market with 14.8% growth ve
